Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
London, UK, 23 March 2026 - Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic Low Back Pain (cLBP), today announces that it has appointed Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer, succeeding Steve Ruston, who is retiring after 13 years at the company. Steve will remain on Persica's board as a Non-Executive Director. These leadership changes further strengthen the company at a critical point in its development, following the positive Phase 1b clinical data for PP353, a targeted intradiscal therapy for cLBP associated with Modic changes. The randomised, double-blind, sham-controlled (placebo) trial showed that PP353 significantly reduced pain, improved patients' ability to function in daily life, and reduced their use of painkillers, including opioids. The data was published in The Lancet's eClinicalMedicine earlier this year and was selected for an oral presen
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive OfficerGlobeNewswire
- Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting [Yahoo! Finance]Yahoo! Finance
- Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meetingGlobeNewswire
- Immunocore (IMCR) was downgraded by Jefferies Financial Group Inc. from "buy" to "hold". They now have a $33.00 price target on the stock.MarketBeat
- Immunocore to present at upcoming investor conferencesGlobeNewswire
IMCR
Earnings
- 2/25/26 - Miss
IMCR
Sec Filings
- 3/11/26 - Form 144
- 3/6/26 - Form SCHEDULE
- 2/25/26 - Form 8-K
- IMCR's page on the SEC website